Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Depresión y ansiedad en la enfermedad inflamatoria intestinal
Información de la revista
Vol. 32. Núm. S2.
Psicología y enfermedad inflamatoria intestinal
Páginas 9-12 (Octubre 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 32. Núm. S2.
Psicología y enfermedad inflamatoria intestinal
Páginas 9-12 (Octubre 2009)
Psicología y enfermedad inflamatoria intestinal
Acceso a texto completo
Depresión y ansiedad en la enfermedad inflamatoria intestinal
Depression and anxiety in inflammatory bowel disease
Visitas
...
Gabriele Moser
Clinic of Internal Medicine III, Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

El modelo biopsicosocial supone una ventaja sobre el modelo biomédico, ya que el primero incorpora las complejas interacciones biológicas y psicosociales que explican la enfermedad humana o sus efectos. Prestar atención a los factores psicosociales asociados con la enfermedad inflamatoria intestinal tiene efecto en el bienestar psicosocial y la calidad de vida. Los trastornos psicológicos parecen ser consecuencia de la enfermedad. El grado de malestar y perturbación psicológica está correlacionado con la gravedad de la enfermedad, predice la calidad de vida relacionada con la salud e influye en el curso de la enfermedad. Particularmente, los médicos deberían evaluar la ansiedad y la depresión entre sus pacientes con enfermedad activa o dolor abdominal en remisión. Este artículo examina estudios dedicados a evaluar la repercusión de la depresión y la ansiedad en la enfermedad inflamatoria intestinal, y destaca la importancia de integrar la atención psicosomática en la práctica clínica.

Palabras clave:
Enfermedad inflamatoria intestinal
Enfermedad de Crohn
Colitis ulcerosa
Psicología
Depresión
Ansiedad
Abstract

The biopsychosocial model represents an advantage over the biomedical model, since it embodies the complex biological and psychosocial interactions that explain human illness or its effects. Attention to the psychosocial factors associated with inflammatory bowel disease have consequences on psychosocial well-being and quality of life. Psychological disturbances seem to be a consequence of the illness. The degree of psychological distress and disturbances correlates with the disease severity, predicts health-related quality of life and influences the course of disease. Clinicians should particularly assess anxiety and depression among their patients with active disease and / or abdominal pain in remission. This article reviews studies about the impact of depression and anxiety in inflammatory bowel diseases, and will show the importance to integrate psychosomatic care into clinical practice.

Keywords:
Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Psychology
Depression
Anxiety
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Moser, W. Tillinger, G. Sachs, D. Genser, T.H. Maier-Dobersberger, K. Spiess, et al.
Disease related concerns – a study on outpatients with inflammatory bowel disease (IBD).
Eur J Gastroenterol Hepatol, 7 (1995), pp. 853-858
[2.]
D.A. Drossman, J. Leserman, Z. Li, M. Mitchell, E.A. Zagami, D.L. Patrick.
The rating form of IBD patient concerns: A new measure of health status.
Psychosomatic Medicine, 53 (1991), pp. 701-712
[3.]
I. Engström, B.L. Lindquist.
Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation.
Acta Paed Scand, 80 (1991), pp. 640-647
[4.]
J.E. Helzer, W.A. Stillings, S. Chammas, C.C. Norland, D.H. Alpers.
A controlled study of the association between ulcerative colitis and psychiatric diagnoses.
Dig Dis Sci, 27 (1982), pp. 513-518
[5.]
J.E. Helzer, S. Chammas, C.C. Norland, W.A. Stillings, D.H. Alpers.
A study of the association between Crohn's disease and psychiatric illness.
Gastroenterology, 86 (1984), pp. 324-330
[6.]
G. Addolorato, G.F. Stefanini, E. Capristo, F. Caputo, A. Gasbarrini, G. Gasbarrini.
Anxiety and depression in adult coeliac subjects and in patients affected by inflammatory bowel disease: a personality trait or a reactive illness.
Hepato Gastroenterol, 43 (1996), pp. 1513-1517
[7.]
C.S. North, R.E. Clouse, E.L. Spitznagel, D.H. Alpers.
The relation of ulcerative colitis to psychiatric factors: a review of findings and methods.
Am J Psychiatry, 147 (1990), pp. 974-981
[8.]
P. Porcelli, C. Leoci, V. Guerra.
A prospective study of the relationship between disease activity and psychologic distress in patients with IBD.
Scand J Gastroenterol, 31 (1996), pp. 792-796
[9.]
L.M. Kurina, M.J. Goldacre, D. Yeates, L.E. Gill.
Depression and anxiety in people with inflammatory bowel disease.
J Epidemiol Commun Health, 55 (2001), pp. 716-720
[10.]
K. Nordin, L. Pahlman, K. Larsson, M. Sundström-Hjelm, L. Lööf.
Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease.
Scand J Gastroenterol, 37 (2002), pp. 450-457
[11.]
E. Guthrie, J. Jackson, J. Shaffer, D. Thompson, B. Tomenson, F. Creed.
Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
Am J Gastroenterol, 97 (2002), pp. 1994-1999
[12.]
D.A. Drossman, J. Leserman, C.M. Mitchell, Z. Li, E.A. Zagami, D.L. Patrick.
Health status and health care use in persons with inflammatory bowel disease. A national sample.
Dig Dis Sci, 36 (1991), pp. 1746-1755
[13.]
L.M. Lix, L.A. Graff, J.R. Walker, I. Clara, P. Rawsthorne, L. Rogala, et al.
Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease.
Inflamm Bowel Dis, 14 (2008), pp. 1575-1584
[14.]
A.A. Mikocka-Walus, D.A. Turnbull, N.T. Moulding, I.G. Wilson, J.M. Andrews, G.J. Holtmann.
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review.
Inflamm Bowel Dis, 13 (2007), pp. 225-234
[15.]
A.A. Mikocka-Walus, D.A. Turnbull, N.T. Moulding, I.G. Wilson, J.M. Andrews, G.J. Holtmann.
“It doesn’t do any harm, but patients feel better”: a qualitative exploratory study on gastroenterologists’ perspectives on the role of antidepressants in inflammatory bowel disease.
BMC Gastroenterol, 7 (2007), pp. 38
[16.]
E. Fuller-Thomson, J. Sulman.
Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.
Inflamm Bowel Dis, 12 (2006), pp. 697-707
[17.]
A.S. Zigmond, R.P. Snaith.
The hospital anxiety and depression scale.
Acta Psychiatrica Scand, 67 (1983), pp. 361-370
[18.]
R.E. Tarter, J. Switala, J. Carra, K.L. Edwards, D.H. Van Tbiel.
Inflammatory bowel disease. psychiatric status of patients before and after disease onset.
Int J Psychiatry Med, 17 (1987), pp. 173-181
[19.]
W. Miehsler, M. Weichselberger, A. Offerlbauer-Ernst, C. Dejaco, W. Reinisch, H. Vogelsang, et al.
Which patients with IBD need psychological interventions? A controlled study.
Inflamm Bowel Dis, 14 (2008), pp. 1273-1280
[20.]
A.A. Mikocka-Walus, D.A. Turnbull, J.M. Andrews, N.T. Moulding, I.G. Wilson, H.A. Harley, et al.
Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C.
Clin Pract Epidemol Ment Health, 4 (2008), pp. 15
[21.]
C. Mittermaier, C. Dejaco, T. Waldhoer, A. Öfferlbauer, W. Miehsler, M. Beier, et al.
Impact of depressive mood on relapse in patients with inflammatory bowel disease – a prospective 18 months follow up study.
Psychosomatic Medicine, 66 (2004), pp. 79-84
[22.]
H. Andrews, P. Barczak, R.N. Allan.
Psychiatric illness in patients with inflammatory bowel disease.
Gut, 28 (1987), pp. 1600-1604
[23.]
S. Levenstein, C. Prantera, V. Voarvo, et al.
Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission.
Am J Gastroenterol, 95 (2000), pp. 1213-1220
[24.]
H.E. Mardini, K.E. Kip, J.W. Wilson.
Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity.
Dig Dis Sci, 49 (2004), pp. 492-497
[25.]
A. Vidal, E. Gómez-Gil, M. Sans, M.J. Portella, M. Salamero, J.M. Piqué, et al.
The impact of anxiety and depression on relapse in patients with inflammatory bowel disease.
Med Clin (Barc), 132 (2009), pp. 298-302
[26.]
A. Bitton, P.L. Dobkin, M.D. Edwardes, M.J. Sewitch, J.B. Meddings, S. Rawal, et al.
Predicting relapse in Crohn's disease: a biopsychosocial model.
Gut, 57 (2008), pp. 1386-1392
[27.]
R. Caprilli, M.A. Gassull, J.C. Escher, G. Moser, P. Munkholm, A. Forbes, et al.
for the European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
[28.]
L. Biancone, P. Michetti, S. Travis, J.C. Escher, G. Moser, A. Forbes, et al.
for the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the management of ulcerative colitis: special situations.
J Crohn Colitis, 2 (2008), pp. 63-92
[29.]
W. Miehsler, M. Weichselberger, A. Offerlbauer-Ernst, C. Dejaco, W. Reinisch, H. Vogelsang, et al.
Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease.
Inflamm Bowel Dis, 10 (2004), pp. 637-645
[30.]
C. Herrmann.
International experience with the hospital anxiety and depression scale-a review of validation data and clinical results.
J Psychosom Res, 42 (1997), pp. 17-41
[31.]
A. De Boer, M. Sprangers, J. Bartelsman, H. Haes.
Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study.
Eur J Gastroenterol Hepatol, 10 (1998), pp. 783-789
Copyright © 2009. Elsevier España S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos